Skip to Content

Disclaimer

Disclaimer
MDS makes every effort to publish accurate information on the website. "Google Translate" is provided as a free tool for visitors to read content in one's native language. Translations are not guaranteed to be 100% accurate. Neither MDS nor its employees assume liability for erroneous translations of website content.

 

International Congress of Parkinson’s Disease and Movement Disorders ®

Congress
Main Content

Therapeutic Plenary Session 1103

Device-Aided and Surgical Therapies for Parkinson’s Disease

Panel Discussion

Sunday, October 5, 2025
13:30 - 15:00 | Room TBD

In this session, the faculty will present an in-depth exploration of device-aided and surgical therapies for Parkinson’s disease. A practical approach on patient selection with Illustrative video cases will be discussed.


Chairs:

Jose Obeso, Spain
Mayela Rodriguez Violante, Mexico

Presenters:

Apomorphine Therapies and Levodopa Infusions
K Ray Chaudhuri, United Kingdom

DBS and MRgFUS
Elena Moro, France

Criteria for Patient Selection
Thomas Kimber, Australia

CSPC Liaisons:

Mayela Rodriguez Violante, Mexico

Learning Objectives

At the conclusion of this session, participants should be better able to:

  1. Analyze efficacy, tolerability, and safety of apomorphine therapies and levodopa infusions in Parkinson’s disease
  2. Analyze efficacy, tolerability, and safety of DBS and MR-guided focused ultrasound in Parkinson’s disease
  3. Assess the criteria for patient selection for each of these methods

Recommended Audience

Clinician / General Neurology
Fellow / Resident / Student
Health Professional (non-physician)
Industry
Researcher / Basic Science

Education Level

Advanced / Expert
Beginner / Foundational
Intermediate / Experienced

Focus

Clinical